Today : Feb 04, 2025
Health
03 February 2025

Twelve New Mpox Vaccination Sites Open Across England

Expansion facilitates wider access amid rising mpox cases and new strains detected.

Health officials have announced the opening of twelve new mpox vaccination sites across England, significantly increasing access to vaccinations for those deemed at higher risk of contracting the infection.

This expansion ensures every area of the country can now offer jabs to vulnerable populations, reflecting the UK's growing response to the mpox virus, particularly as new strains emerge.

Prior to this initiative, eligible individuals could only receive the vaccine at 19 designated sites, primarily located in London, Brighton, and Manchester. The newly established sites span various regions, including Birmingham, Nottingham, Sheffield, Sunderland, Hull, Leeds, Liverpool, Blackpool, Southampton, Bristol, Exeter, and Hatfield.

According to Steve Russell, NHS national director for vaccination and screening, "The NHS is fully prepared to respond to mpox and the latest cases of clade 1b, with local services pulling out all the stops to vaccinate those eligible since it first became present in England, and tens of thousands in priority groups already coming forward and getting protected." He highlighted the importance of ensuring eligible individuals across England can easily access the mpox vaccines.

The recent expansion of vaccination sites stems from the detection of new mpox cases. The UK has reported its first case of clade 1b mpox—the variant now spreading widely through several African nations—just last month. Since October, another case has already been identified, which has heightened the urgency for increased vaccination efforts.

Officials noted the risk of mpox to the general public remains low. Still, they stress the importance of access to vaccines as new cases of clade 1b are confirmed. The current guidelines aim to offer protection to groups identified as being at greater risk, including men who have sex with men and those with multiple partners.

Symptoms of mpox can include skin rashes with blisters or spots, fever, headache, and muscle pains. Such symptoms typically appear within one to five days after initial fever signs. Health experts warn about the virus's contagious nature, as it can spread through direct contact with rashes, skin lesions, or scabs. Other modes of transmission include sexual contact, close skin-to-skin interactions, and contact with contaminated bedding, towels, and even through airborne transmission during prolonged face-to-face interactions.

Dr. Sema Mandal, consultant epidemiologist and deputy director at the UK Health Security Agency (UKHSA), remarked, "It’s great to see mpox vaccination now available in every region across England, offering gay, bisexual, and other men who have sex with men at highest risk the opportunity for vitally protection against the disease." She emphasized the necessity of seeking medical advice when symptoms present and the continuing importance of vaccination even with low case numbers of clade 2 mpox reported.

With health officials pushing for greater vaccination uptake among eligible individuals, they encourage those who meet the criteria to visit the NHS website to locate the nearest vaccination site. The recent expansion of locations is seen not only as proactive public health strategy but also as reaffirming the available resources and preparation for safeguarding at-risk communities.

The newly established vaccination sites reflect extensive efforts by the NHS and UKHSA to adjust to the mpox situation's dynamics proactively. Vaccination remains one of the key strategies to mitigate the spread of mpox as the healthcare system navigates the uncertainties brought by new strains.

Russian officials are working tirelessly to protect public health and provide the necessary resources and support to combat mpox effectively. They're hoping to achieve optimal vaccination coverage by making it easier for those at risk to get jabbed and stay safe from this viral threat.

Taking action now means ensuring the safety and well-being of high-risk groups. With efficient access to vaccinations across England, the NHS and health officials aim to retain control over the potential spread of mpox.